Skip to main content
Caplight Logo









Insamo

Insamo

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.insamo.com/

Last Round

Seed

Feb 21, 2024

Total Funding Raised

$12M

Company Overview

Insamo is a biotechnology company that specializes in the discovery of membrane-permeable and orally-available cyclic-peptides with antibody-like binding affinity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

macrocyclic drugsdrug discoverybiotechcomputational chemistrymolecular designAI drug discoverysynthetic chemistrymacrocyclesundruggable targetstherapeutic candidatesin silico drug designbiopharmadrug developmentpreclinical researchsmall molecule alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Insamo Comparables

Compare Insamo with similar companies based on industry and business-model similarity.

Insamo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vilya
88%
BRT Biotechnologies
87%
Curve Therapeutics
86%

Insamo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 21, 2024

Key People

Founding team and executive leadership

Timothy Craven

Co-founder And CEO

Founding Team

Insamo Investors

Notable investors and investment history

Insamo Filings

Explore SEC and related filing metadata, where available.

Insamo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Insamo's valuation, stock price, and market status.

Is Insamo a public or private company?

Insamo is a private company.

What is the current stock price of Insamo?

Insamo is a private company with no public stock price. No recent secondary market data is available.

How much is Insamo worth (valuation)?

Valuation information for Insamo is not publicly available.

Can I buy Insamo stock?

Insamo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Insamo's last funding round?

Insamo's most recent funding round was Seed on February 21, 2024.

Who are the main investors in Insamo?

Key investors in Insamo include Playground Global, venBio.

Will Insamo IPO soon?

No public IPO plans have been announced for Insamo.

How can I track Insamo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Insamo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range13
Year Founded2022
Last FundingFeb 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?